Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07088354

Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy

Status
Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Tongji Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to develop and validate a deep learning model to predict pathological complete response (pCR) in patients with esophageal squamous cell carcinoma who have undergone neoadjuvant immunochemotherapy. Clinical, imaging, and pathological data from previously treated patients will be collected and analyzed. The model is expected to assist in predicting treatment outcomes and guide personalized therapeutic strategies.

Detailed description

This multicenter retrospective study will collect chest CT images and clinical data from patients with esophageal squamous cell carcinoma (ESCC) who underwent surgery following neoadjuvant immunochemotherapy between January 2019 and July 2025. Deep learning features will be extracted from the CT images to develop a predictive model of pathological complete response (pCR). The model's performance will be evaluated using metrics including the area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Additionally, SHapley Additive exPlanations (SHAP) analysis will be employed to quantify the contribution of CT imaging features to the model's predictions. This study aims to improve early identification of responders to neoadjuvant immunochemotherapy and support personalized treatment strategies for ESCC patients.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTThe high-throughput extraction of large amounts of quantitative image features from medical imagesThe high-throughput extraction of large amounts of quantitative image features from medical images

Timeline

Start date
2025-03-01
Primary completion
2026-06-01
Completion
2026-12-01
First posted
2025-07-28
Last updated
2025-07-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07088354. Inclusion in this directory is not an endorsement.